ArticleCureus2025
Neutrophil-to-Lymphocyte Ratio Correlation With the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Score in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe neutrophil-to-lymphocyte ratio (NLR) is a simple inflammatory marker that may reflect the extent of coronary atherosclerotic complexity. This study examined the relationship between NLR and angiographic disease severity in individuals presenting with non-ST-segment elevation acute coronary syndrome (NSTE-ACS), using the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score as an anatomical reference standard.
methodsIn this prospective observational study, 100 consecutive patients with NSTE-ACS underwent coronary angiography at two tertiary centres in Egypt between July 2020 and June 2021. Patients with persistent ST-segment elevation, active infection, chronic inflammatory diseases, malignancy, chronic obstructive pulmonary disease, or chronic steroid use were excluded. A single baseline NLR measurement was obtained at admission before angiography. Laboratory testing at both centres used the same automated analyser. SYNTAX scoring was performed independently by two interventional cardiologists who were blinded to clinical and laboratory data, with discrepancies resolved by consensus. Patients were stratified into three tertiles based on admission NLR: low NLR (≤3.65), intermediate NLR (>3.65 to ≤5.1), and high NLR (>5.1). Associations between NLR, SYNTAX score, and clinical variables were analysed using univariable methods because the number of high SYNTAX cases and 30-day mortality events did not permit reliable multivariable modelling.
resultsThe mean age of the cohort was 46.5±7.4 years, and 77.0% were male. Diabetes mellitus, hypertension, and smoking were present in 66, 67, and 74 percent of patients, respectively. The mean SYNTAX score was 15.6±9.1, and the mean NLR was 4.7±1.6. A moderate positive correlation was observed between NLR and SYNTAX score (r=0.48, p<0.001). SYNTAX scores increased progressively across NLR categories, with mean values of 11.27 in the low group, 15.0 in the intermediate group, and 17.79 in the high group. Only seven patients (7.0 %) had a SYNTAX score ≥33, which limits the precision of subgroup estimates. An NLR greater than 5.5 identified patients with SYNTAX ≥33 with 100% sensitivity, 77.4% specificity, a positive predictive value (PPV) of 75%, a negative predictive value (NPV) of 100%, and an area under the ROC curve of 0.88 (95% CI: 0.78-0.95). During the 30-day follow-up, four patients died. An NLR greater than 5.4 predicted 30-day mortality with 100% sensitivity, 72.9% specificity, and an AUC of 0.86 (95% CI: 0.71-0.97). Mortality-related estimates should be interpreted cautiously because of the small number of events.
conclusionsIn NSTE-ACS, NLR correlates with the anatomical complexity of coronary artery disease and may provide useful supplementary information during early risk assessment. However, the proposed threshold should be regarded as exploratory because of the limited number of patients with very high SYNTAX scores and the small number of mortality events. NLR should be considered a complementary marker rather than a replacement for established clinical risk stratification tools. Larger, multicentre studies with external validation are needed before NLR-based thresholds can be integrated into routine clinical pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.